Tianjin Medical Journal ›› 2023, Vol. 51 ›› Issue (6): 662-667.doi: 10.11958/20221665
• Applied Research • Previous Articles Next Articles
ZHANG Wenjing1(), WEN Dehui2,△, ZHENG Yingjuan2, LI Chaoxi2, NIU Yajun2, MIAO Qing1
Received:
2022-10-14
Revised:
2023-02-03
Published:
2023-06-15
Online:
2023-06-20
Contact:
△E-mail:ZHANG Wenjing, WEN Dehui, ZHENG Yingjuan, LI Chaoxi, NIU Yajun, MIAO Qing. The study of QAS combined with QIMT technology on carotid atherosclerosis in patients with normal high blood pressure[J]. Tianjin Medical Journal, 2023, 51(6): 662-667.
CLC Number:
组别 | n | 性别(男/女) | 年龄(岁) | BMI(kg/m2) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
血压正常组 | 82 | 19/63 | 54.50(49.00,58.25) | 26.66±3.27 | ||||||
正常高值血压组 | 90 | 34/56 | 55.00(51.75,59.25) | 25.87±3.11 | ||||||
高血压组 | 68 | 23/45 | 57.00(50.00,62.50) | 25.86±3.53 | ||||||
χ2或F | 4.435 | 4.845 | 1.597 | |||||||
组别 | 收缩压 (mmHg) | 舒张压 (mmHg) | TG (mmol/L) | |||||||
血压正常组 | 113(109,118) | 75(72,79) | 1.43(1.04,1.97) | |||||||
正常高值血压组 | 132(128,137)a | 85.00(82,89)a | 1.37(1.04,2.19) | |||||||
高血压组 | 150(142,158)ab | 91(85,98)ab | 1.87(1.42,2.93)ab | |||||||
χ2或F | 190.972** | 102.484** | 12.928** | |||||||
组别 | TC (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) | |||||||
血压正常组 | 4.26(3.70,4.88) | 1.23(1.11,1.29) | 2.47(2.06,2.82) | |||||||
正常高值血压组 | 4.56(3.97,5.40) | 1.07(0.85,1.30)a | 3.68(2.52,4.59)a | |||||||
高血压组 | 4.73(3.86,5.39)a | 1.04(0.58,1.29)a | 2.97(2.28,5.38)a | |||||||
χ2或F | 6.184* | 13.355** | 36.745** |
Tab.1 Comparison of clinical data and laboratory indexes between the three groups
组别 | n | 性别(男/女) | 年龄(岁) | BMI(kg/m2) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
血压正常组 | 82 | 19/63 | 54.50(49.00,58.25) | 26.66±3.27 | ||||||
正常高值血压组 | 90 | 34/56 | 55.00(51.75,59.25) | 25.87±3.11 | ||||||
高血压组 | 68 | 23/45 | 57.00(50.00,62.50) | 25.86±3.53 | ||||||
χ2或F | 4.435 | 4.845 | 1.597 | |||||||
组别 | 收缩压 (mmHg) | 舒张压 (mmHg) | TG (mmol/L) | |||||||
血压正常组 | 113(109,118) | 75(72,79) | 1.43(1.04,1.97) | |||||||
正常高值血压组 | 132(128,137)a | 85.00(82,89)a | 1.37(1.04,2.19) | |||||||
高血压组 | 150(142,158)ab | 91(85,98)ab | 1.87(1.42,2.93)ab | |||||||
χ2或F | 190.972** | 102.484** | 12.928** | |||||||
组别 | TC (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) | |||||||
血压正常组 | 4.26(3.70,4.88) | 1.23(1.11,1.29) | 2.47(2.06,2.82) | |||||||
正常高值血压组 | 4.56(3.97,5.40) | 1.07(0.85,1.30)a | 3.68(2.52,4.59)a | |||||||
高血压组 | 4.73(3.86,5.39)a | 1.04(0.58,1.29)a | 2.97(2.28,5.38)a | |||||||
χ2或F | 6.184* | 13.355** | 36.745** |
性别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
男性 | 19 | 535.50(471.00,658.00) | 0.03(0.02,0.03) | 1.09(0.96,1.46) | 3.77(2.79,4.47) | 7.69(5.75,9.11) | 6.00(5.76,7.32) |
女性 | 63 | 532.00(497.00,594.00) | 0.03(0.02,0.03) | 1.07(0.87,1.26) | 3.30(2.78,5.11) | 6.71(5.73,10.16) | 6.16(5.5,7.40) |
Z | 0.522 | 0.006 | 0.681 | 0.027 | 0.176 | 0.060 |
Tab.2 Comparison of carotid IMT and elastic parameters between different genders in the normal blood pressure group
性别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
男性 | 19 | 535.50(471.00,658.00) | 0.03(0.02,0.03) | 1.09(0.96,1.46) | 3.77(2.79,4.47) | 7.69(5.75,9.11) | 6.00(5.76,7.32) |
女性 | 63 | 532.00(497.00,594.00) | 0.03(0.02,0.03) | 1.07(0.87,1.26) | 3.30(2.78,5.11) | 6.71(5.73,10.16) | 6.16(5.5,7.40) |
Z | 0.522 | 0.006 | 0.681 | 0.027 | 0.176 | 0.060 |
性别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
男性 | 34 | 654.63±131.83 | 0.02(0.02,0.02) | 0.87(0.63,1.09) | 4.26(3.41,5.33) | 8.67(6.97,10.86) | 7.54(6.84,8.24) |
女性 | 56 | 582.81±106.56 | 0.02(0.02,0.02) | 0.81(0.60,0.92) | 4.29(3.57,5.28) | 8.61(7.17,10.75) | 7.44(6.76,8.44) |
Z或t | 2.122* | 0.524 | 1.020 | 0.187 | 0.358 | 0.258 |
Tab.3 Comparison of carotid IMT and elastic parameters between different genders in the normal high-value blood pressure group
性别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
男性 | 34 | 654.63±131.83 | 0.02(0.02,0.02) | 0.87(0.63,1.09) | 4.26(3.41,5.33) | 8.67(6.97,10.86) | 7.54(6.84,8.24) |
女性 | 56 | 582.81±106.56 | 0.02(0.02,0.02) | 0.81(0.60,0.92) | 4.29(3.57,5.28) | 8.61(7.17,10.75) | 7.44(6.76,8.44) |
Z或t | 2.122* | 0.524 | 1.020 | 0.187 | 0.358 | 0.258 |
性别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
男性 | 23 | 591.35±90.84 | 0.02(0.01,0.02) | 0.88(0.61,1.14) | 4.18(3.24,5.75) | 8.54(6.64,11.71) | 7.99±1.58 |
女性 | 45 | 604.01±118.64 | 0.01(0.01,0.02) | 0.65(0.21,0.87) | 5.29(4.42,7.21) | 10.77(9.04,14.63) | 9.00±1.83 |
Z或t | 0.700 | 1.924 | 2.308* | 2.353* | 2.359* | 2.230* |
Tab.4 Comparison of carotid IMT and elastic parameters between different genders in the hypertension group
性别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
男性 | 23 | 591.35±90.84 | 0.02(0.01,0.02) | 0.88(0.61,1.14) | 4.18(3.24,5.75) | 8.54(6.64,11.71) | 7.99±1.58 |
女性 | 45 | 604.01±118.64 | 0.01(0.01,0.02) | 0.65(0.21,0.87) | 5.29(4.42,7.21) | 10.77(9.04,14.63) | 9.00±1.83 |
Z或t | 0.700 | 1.924 | 2.308* | 2.353* | 2.359* | 2.230* |
侧别 | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|
左侧 | 615.27±137.85 | 0.02(0.01,0.02) | 0.82(0.61,1.03) | 4.13(3.24,5.48) | 8.30(6.63,11.03) | 7.38(6.53,8.37) |
右侧 | 604.62±131.71 | 0.02(0.01,0.02) | 0.78(0.59,1.00) | 4.80(3.51,5.64) | 8.35(7.18,11.48) | 7.27(6.83,8.45) |
Z或t | 0.856 | 0.144 | 0.117 | 0.728 | 0.986 | 0.503 |
Tab.5 Comparison of elastic parameters and IMT between the left and right carotid arteries in patients with high-normal blood pressure
侧别 | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|
左侧 | 615.27±137.85 | 0.02(0.01,0.02) | 0.82(0.61,1.03) | 4.13(3.24,5.48) | 8.30(6.63,11.03) | 7.38(6.53,8.37) |
右侧 | 604.62±131.71 | 0.02(0.01,0.02) | 0.78(0.59,1.00) | 4.80(3.51,5.64) | 8.35(7.18,11.48) | 7.27(6.83,8.45) |
Z或t | 0.856 | 0.144 | 0.117 | 0.728 | 0.986 | 0.503 |
组别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
血压正常组 | 82 | 535.25(477.00,609.50) | 0.03(0.02,0.03) | 1.09(0.88,1.26) | 3.32(2.79,4.63) | 6.73(5.74,9.17) | 6.16(5.69,7.33) |
正常高值血压组 | 90 | 602.00(529.50,684.25)a | 0.02(0.02,0.02)a | 0.82(0.63,1.00)a | 4.26(3.54,5.27)a | 8.66(7.11,10.72)a | 7.48(6.79,8.25)a |
高血压组 | 68 | 608.50(522.88,671.00)a | 0.02(0.01,0.02)a | 0.69(0.53,1.01)a | 5.23(3.84,6.82)a | 10.61(7.86,13.89)a | 8.40(7.36,9.82)ab |
χ2 | 16.002** | 53.182** | 40.016** | 27.505** | 29.527** | 67.298** |
Tab.6 Comparison of carotid artery MIT and elastic parameters between different blood pressure groups
组别 | n | IMT(μm) | DC(mm2/kPa) | CC(mm2/kPa) | α | β | PWV(m/s) |
---|---|---|---|---|---|---|---|
血压正常组 | 82 | 535.25(477.00,609.50) | 0.03(0.02,0.03) | 1.09(0.88,1.26) | 3.32(2.79,4.63) | 6.73(5.74,9.17) | 6.16(5.69,7.33) |
正常高值血压组 | 90 | 602.00(529.50,684.25)a | 0.02(0.02,0.02)a | 0.82(0.63,1.00)a | 4.26(3.54,5.27)a | 8.66(7.11,10.72)a | 7.48(6.79,8.25)a |
高血压组 | 68 | 608.50(522.88,671.00)a | 0.02(0.01,0.02)a | 0.69(0.53,1.01)a | 5.23(3.84,6.82)a | 10.61(7.86,13.89)a | 8.40(7.36,9.82)ab |
χ2 | 16.002** | 53.182** | 40.016** | 27.505** | 29.527** | 67.298** |
[1] | CHOBANIAN A V, BAKRIS G L, BLACK H R, et al. The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure: the JNC 7 report[J]. JAMA, 2003, 289(19):2560-2572. doi:10.1001/jama.289.19.2560. |
[2] | 迟相林. 是否应保留高血压前期(正常高值血压)的概念? 高血压前期有哪些危害,该如何处理?[J]. 中华高血压杂志, 2021, 29(5):405-412. |
CHI X L. Should we retain the concept of prehypertension(normal high blood pressure)? What are the hazards of prehypertension, how to deal with?[J]. Chin J Hypertens, 2021, 29(5):405-412. doi:10.16439/j.issn.1673-7245.2021.05.002. | |
[3] | ZANOLI L, LENTINI P, BRIET M, et al. Arterial stiffness in the heart disease of CKD[J]. J Am Soc Nephrol, 2019, 30(6):918-928. doi:10.1681/ASN.2019020117. |
[4] | 中国高血压防治指南修订委员会, 高血压联盟中国, 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56. |
Chinese Hypertension Prevention and Treatment Guidelines Revision Committee,Hypertension Alliance(China),Cardiovascular Disease Branch of Chinese Medical Association, et al. Guidelines for the prevention and treatment of hypertension in China(2018 revised edition)[J]. Chin J Cardiovasc Med, 2019, 24(1):24-56. doi:10.3969/j.issn.1007-5410.2019.01.002. | |
[5] | 丹海俊, 吴月娥, 郭艾楠, 等. 射频数据处理技术早期评估2型糖尿病患者颈总动脉硬化[J]. 中华超声影像学杂志, 2019, 28(8):720-722. |
DAN H J, WU Y E, GUO A N, et al. Early assessment of common carotid atherosclerosis in patients with type 2 diabetes by RF data processing technology[J]. Chin J Ultrasonogr, 2019, 28(8):720-722. doi:10.3760/cma.j.issn.1004-4477.2019.08.016. | |
[6] | 梁占东, 刘彦芳, 张晓辰, 等. 基于CT成像分析正常高值血压伴腹型肥胖者的升主动脉弹性特点[J]. 临床放射学杂志, 2022, 41(6):1038-1042. |
LIANG Z D, LIU Y F, ZHANG X C, et al. Analysis of ascending aorta elasticity in patients with high-normal blood pressure and abdominal obesity based on CT imaging[J]. Journal of Clinical Radiology, 2022, 41(6):1038-1042. doi:10.13437/j.cnki.jcr.2022.06.008. | |
[7] | 秦川, 魏亚巧, 朱小燕. 超声射频信号分析评价健康成人颈总动脉结构及功能的研究[J]. 临床超声医学杂志, 2020, 22(10):759-763. |
QIN C, WEI Y Q, ZHU X Y. Evaluation of common carotid arterial function and structure in healthy adults by ultrasound radio frequency data technology[J]. J Clin Ultrasound in Med, 2020, 22(10):759-763. doi:10.16245/j.cnki.issn1008-6978.2020.10.011. | |
[8] | 王辰, 张亮, 薛丹, 等. 日常运动与颈动脉血管弹性的关系—基于超声射频信号技术的健康人群研究[J]. 心脏杂志, 2021, 33(5):518-522. |
WANG C, ZHANG L, XUE D, et al. Daily physical activity improves carotid artery elasticity-a study based on ultrasound radio frequency signal technique[J]. Chin Heart J, 2021, 33(5):518-522. doi:10.12125/j.chj.202108001. | |
[9] | 易子塬. 颈部血管彩超对动脉硬化性脑梗死的临床价值[J]. 中国现代药物应用, 2021, 15(14):31-33. |
YI Z Y. Clinical value of cervical vascular ultrasonography in the diagnosis of atherosclerotic cerebral infarction[J]. Chin J Mod Drug Appl, 2021, 15(14):31-33. doi:10.14164/j.cnki.cn11-5581/r.2021.14.009. | |
[10] | LIU W, CHEN Z, ORTEGA D, et al. Arterial elasticity,endothelial function and intracranial vascular health:A multimodal MRI study[J]. J Cereb Blood Flow Metab, 2021, 41(6):1390-1397. doi:10.1177/0271678X20956950. |
[11] | 陈重泽, 曾诚, 杨如容, 等. 颈动脉射频超声诊断闽东畲族无症状高血压[J]. 中国介入影像与治疗学, 2021, 18(8):470-473. |
CHEN C Z, ZENG C, YANG R R, et al. Carotid artery radiofrequency ultrasound for diagnosis of asymptomatic hypertension in Mindong She minority[J]. Chin J Interv Imaging Ther, 2021, 18(8):470-473. doi:10.13929/j.issn.1672-8475.2021.08.005. | |
[12] | GAO L, LU D, XIA G, et al. The relationship between arterial stiffness index and coronary heart disease and its severity[J]. BMC Cardiovasc Disord, 2021, 21(1):527. doi:10.1186/s12872-021-02350-6. |
[13] | 林萍. 老年高血压患者HMGB1水平与血管内皮功能及动脉粥样硬化的相关性研究[J]. 医药论坛杂志, 2022, 43(15):31-34. |
LIN P. Correlation of HMGB1 level with vascular endothelial function and atherosclerosis in elderly patients with hypertension[J]. J Medical Forum, 2022, 43(15):31-34. | |
[14] | LIU D, DU C, SHAO W, et al. Diagnostic role of carotid intima-media thickness for coronary artery disease:A meta-analysis[J]. Biomed Res Int, 2020, 2020:9879463. doi:10.1155/2020/9879463. |
[15] | 熊超芳, 王露, 练为芳, 等. 早期原发性高血压患者血管内皮功能与颈动脉弹性功能、颈动脉内-中膜厚度的相关性研究[J]. 现代生物医学进展, 2019, 19(3):519-522. |
XIONG C F, WANG L, LIAN W F, et al. Early essential hypertension:Correlation between vascular endothelial function and carotid artery elasticity,carotid artery intima-media thickness[J]. Progress in Modem Biomedicine, 2019, 19(3):519-522. doi:10.13241/j.cnki.pmb.2019.03.028. | |
[16] | 曾宪卿, 段言峰, 何俊, 等. 超声射频信号技术检测脑梗死患者颈动脉的研究[J]. 神经损伤与功能重建, 2016, 11(1):15-17. |
ZENG X Q, DUAN Y F, HE J, et al. Analysis of carotid artery in patients with cerebral infarction using ultrasound radio-frequency technique[J]. Neural Injury And Functional Reconstruction, 2016, 11(1):15-17. doi:10.16780/j.cnki.sjssgncj.2016.01.005. | |
[17] | 张燕凌, 赵夏夏, 崔丽琼, 等. QIMT、QAS技术定量评价老年人颈总动脉内-中膜厚度和血管弹性的研究[J]. 中国医学装备, 2014, 11(B08):102-103. |
ZHANG Y L, ZHAO X X, CUI L Q, et al. The research for quantitative assessmento senile common carotid artery intima-media thichness and elastic vesseles by using QIMT and QAS[J]. China Medical Equipment, 2014, 11(B08):102-103. | |
[18] | 顾亦斌, 顾淑君, 张秋伊, 等. 江苏省35岁及以上成人超重、肥胖、中心性肥胖与高血压的相关性研究[J]. 中华疾病控制杂志, 2022, 26(8):934-938. |
GU Y B, GU S J, ZHANG Q Y, et al. Association between overweight,obesity,central obesity and hypertension in adults aged 35 and above in Jiangsu Province[J]. Chin J Dis Control Prev, 2022, 26(8):934-938. doi:10.16462/j.cnki.zhjbkz.2022.08.011. | |
[19] | 姜帆, 卢柳西, 姜中碧, 等. 颈动脉粥样硬化斑块分布与同侧脑梗死的关系[J]. 检验医学与临床, 2018, 15(6):747-749. |
JIANG F, LU L X, JIANG Z B, et al. Relationship between carotid atherosclerotic plaque distribution and ipsilateral cerebral infarction[J]. Laboratory Medicine and Clinic, 2018, 15(6):747-749. doi:10.3969/j.issn.1672-9455.2018.06.004. | |
[20] | 刘婷, 周琦, 姜珏, 等. 超声射频信号动脉僵硬度分析技术定量评价健康人群颈动脉弹性[J]. 中国超声医学杂志, 2013, 29(5):392-394. |
LIU T, ZHOU Q, JIANG J, et al. Quantitative evaluation of carotid artery elasticity in healthy adults by quantitative arterial stiffness technique[J]. Chinese J Ultrasound Med, 2013, 29(5):392-394. doi:10.3969/j.issn.1002-0101.2013.05.004. | |
[21] | 苏珍珍, 董国锋, 王占科. 低密度脂蛋白表型B与血浆致动脉硬化指数相关性研究[J]. 检验医学与临床, 2022, 19(15):2115-2118. |
SU Z Z, DONG G F, WANG Z K, et al. Correlation between LDL phenotype B and plasma arteriosclerosis index[J]. Laboratory Medicine and Clinic, 2022, 19(15):2115-2118. | |
[22] | 生士凤, 陈静锋, 王佑翔, 等. 正常高值血压人群颈动脉斑块的相关因素[J]. 中华高血压杂志, 2022, 30(10):950-955. |
SHENG S F, CHEN J F, WANG Y X, et al. Related factors of carotid plaque in people with high-normal blood pressure[J]. Chin J Hypertens, 2022, 30(10):950-955. doi:10.16439/j.issn.1673-7245.2022.10.011. | |
[23] | 郁小红, 钱棪梅, 周晨洁, 等. 应用TreeNet算法建立原发性高血压早期预测模型[J]. 预防医学, 2022, 34(9):923-927. |
YU X H, QIAN Y M, ZHOU C J, et al. Establishment of a TreeNet algorithm-based model for early prediction of essential hypertension[J]. Prev Med, 2022, 34(9):923-927. doi:10.19485/j.cnki.issn2096-5087.2022.09.012. |
[1] | WU Caixin, YAN Yan, DENG Yuanlin, DU Yamin, YANG Zhenwen, PAN Qing, YANG Fan. The value of cardiac magnetic resonance in evaluating severe pulmonary hypertension associated with connective tissue disease [J]. Tianjin Medical Journal, 2024, 52(7): 691-694. |
[2] | WANG Hui, PAN Qing, WANG Zhouming, ZHANG Na, YANG Zhenwen, WEI Wei. Analysis of clinical features of mixed connective tissue disease associated with pulmonary arterial hypertension [J]. Tianjin Medical Journal, 2024, 52(7): 701-703. |
[3] | LI Yong, SU Yakun, ZHANG Hongbo, LI Yuan, LI Zhanhu, YAN Xiaoju. Clinical significance of serum asprosin level in patients with early renal damage of essential hypertension [J]. Tianjin Medical Journal, 2024, 52(6): 609-613. |
[4] | ZHENG Kangpeng, TANG Xinguo, XU Qi, FAN Yuting, LIANG Bo, FU Xiaowei, FANG Lu. Nomogram construction and validation for predicting the possibility successful implementation of radical surgery in gallbladder cancer patients [J]. Tianjin Medical Journal, 2024, 52(5): 536-540. |
[5] | ZHANG Liran, ZHAO Yanhua. The predictive value of MP hypertension monitoring system combined with PLGF and PI for preeclampsia [J]. Tianjin Medical Journal, 2024, 52(3): 306-310. |
[6] | CAO Junyang, MA Chunxing, LIU Zhina. Predictive value of vitamin and folic acid levels in gestational diabetes mellitus complicated by preeclampsia [J]. Tianjin Medical Journal, 2024, 52(12): 1278-1282. |
[7] | QIN Chundi, MA Wen, LI Yuan, ZHU Yaquan, LI Yu, ZOU Lin, ZHANG Xin. Butyrate reduces blood pressure in hypertensive rats by activating the G protein-coupled receptor 41/43 pathway [J]. Tianjin Medical Journal, 2023, 51(9): 972-976. |
[8] | ZHANG Zhaoxia, NAN Xingmei, LI Zhanqiang, LU Dianxiang. Research progress on the role of potassium channels and drug intervention in hypoxic pulmonary hypertension [J]. Tianjin Medical Journal, 2023, 51(8): 892-896. |
[9] | ZHENG Yue, MA Yunting, ZHAO Xiaoying, ZHAO Xinxiang. Correlation between homocysteine and left ventricular myocardial fibrosis in hypertensive patients [J]. Tianjin Medical Journal, 2023, 51(4): 395-399. |
[10] | LU Rongzhen, HUANG Jiangnan, PAN Xingshou, LU Ting, LI Jindu, LI Tianzi, TAN Shuhan. Application effect research of different antihypertensive modes in elderly hypertensive patients with coronary heart disease and PCI [J]. Tianjin Medical Journal, 2023, 51(3): 277-281. |
[11] | YANG Guohong, YU Fangfang, CAI Wei, NIU Xiulong, ZHANG Xin, ZHAO Jihong, LI Yuming, CHEN Shaobo. Effects of peripheral blood VEGFR-3+ monocytes on left ventricular remodeling in mice with hypertension [J]. Tianjin Medical Journal, 2023, 51(2): 144-148. |
[12] | XU Xuemei, LI Chunyan, DENG Zhihong, XU Xiaoming, SHI Jing. Analysis of macular choroidal thickness in patients with grade 3 essential hypertension [J]. Tianjin Medical Journal, 2023, 51(2): 176-179. |
[13] | LI Jing, FAN Zhuoran, ZHANG Junnong, SHENG Hongna, HUA Shaofang. Comparative study on clinical characteristics and TyG index in patients with premature preeclampsia and chronic hypertension complicated with preeclampsia [J]. Tianjin Medical Journal, 2023, 51(2): 190-193. |
[14] | YANG Xueyuan, FENG Chao, FENG Jinping. The influence of blood pressure fluctuation on poor prognosis in patients with severe aortic stenosis [J]. Tianjin Medical Journal, 2023, 51(10): 1110-1116. |
[15] | WANG Jiangtao, MA Bohua, SHEN Huihua, HE Jia, YIN Dongfeng, WANG Rui, LI Wu. The effect of halofuginone on cardiopulmonary function and its mechanism in rats with high-altitude pulmonary hypertension [J]. Tianjin Medical Journal, 2023, 51(1): 41-44. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||